BC
Broadfin Capital Portfolio holdings
AUM
$403M
1-Year Return
74.97%
This Quarter Return
+22.65%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.03B
AUM Growth
+$274M
(+36%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
40.17%
Holding
97
New
37
Increased
20
Reduced
20
Closed
12
Top Buys
| 1 |
Travere Therapeutics
TVTX
|
$34.1M |
| 2 |
Heron Therapeutics
HRTX
|
$31.1M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$21M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$20.1M |
| 5 |
Emergent Biosolutions
EBS
|
$18.5M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$29.1M |
| 2 |
LCI
Lannett Company, Inc.
LCI
|
$23.4M |
| 3 |
Assertio
ASRT
|
$22.5M |
| 4 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$16.6M |
| 5 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$14.9M |
Sector Composition
| 1 | Healthcare | 79.95% |
| 2 | Technology | 0.77% |
